|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, Sendai, Japan.
Correspondence to: Hidetada Sasaki, MD, Professor and Chairman, Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan; e-mail: dept{at}geriat.med.tohoku.ac.jp
Purpose: Exhaled carbon monoxide and arterial blood carboxyhemoglobin concentrations increase in inflammatory pulmonary diseases. The present study was undertaken to elucidate whether arteriovenous carboxyhemoglobin (a-vHb-CO) concentration differences are also useful to define the site of inflammation, either in the lung or organs other than the lung.
Materials and methods: We examined concentrations of carboxyhemoglobin in both arterial and peripheral venous blood and exhaled carbon monoxide in patients with acute pulmonary inflammation including bronchial asthma (n = 18) and pneumonia (n = 33), and those in patients with extrapulmonary inflammatory diseases, including acute pyelonephritis (n = 28) and active rheumatoid arthritis (n = 16).
Results: The values of carboxyhemoglobin in both arterial and peripheral venous blood were significantly higher in patients with pulmonary and extrapulmonary inflammation compared with those in control subjects (n = 22). Furthermore, a-vHb-CO differences in patients with inflammatory pulmonary diseases were higher than those in patients with acute pyelonephritis and patients with rheumatoid arthritis, and than those in control subjects. The a-vHb-CO differences correlated with the WBC count of peripheral venous blood in patients with pneumonia. In patients with bronchial asthma, the a-vHb-CO differences inversely correlated with FEV1, although they did not correlate with WBC count of peripheral venous blood. The a-vHb-CO differences in patients with acute pyelonephritis were higher than those in patients with active rheumatoid arthritis.
Conclusion: The present study suggests that a-vHb-CO differences may be a useful means to define the site of inflammation, either in the lung or organs other than the lung, in patients with a fever of unknown origin. The large a-vHb-CO differences may be caused by carbon monoxide production in pulmonary inflammation.
Key Words: carboxyhemoglobin heme oxygenase inflammatory pulmonary disease
This article has been cited by other articles:
![]() |
M. Westphal, T. P. Weber, H. Yasuda, M. Yamaya, K. Nakayama, T. Sasaki, S. Ebihara, T. Ebihara, and H. Sasaki Is the Arteriovenous Carboxyhemoglobin Gradient Really a Useful Marker in Systemic Inflammation? Chest, November 1, 2005; 128(5): 3771 - 3772. [Full Text] [PDF] |
||||
![]() |
S. Permutt and D. B. Pearse Blood Carbon Monoxide Will Increase from a Decline in Pulmonary Function Alone Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1231 - 1231. [Full Text] [PDF] |
||||
![]() |
H. Yasuda, M. Yamaya, K. Nakayama, S. Ebihara, T. Sasaki, S. Okinaga, D. Inoue, M. Asada, M. Nemoto, and H. Sasaki Increased Arterial Carboxyhemoglobin Concentrations in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1246 - 1251. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |